Stock Track | Stevanato Group Shares Surge on Q3 Earnings Beat and Revenue Outlook

Stock Track

2024-11-05

Shares of Stevanato Group S.p.A. (NYSE: STVN), a leading producer of glass vials for COVID-19 vaccines, soared over 5% on Monday after the company reported better-than-expected third-quarter revenue and provided an optimistic full-year revenue outlook.

While the company's Q3 adjusted earnings of €0.12 ($0.13) per share narrowly missed analysts' estimates of €0.13, its revenue of €277.9 million surpassed the consensus estimate of €274.4 million. Stevanato attributed the revenue growth to strong demand for its pharmaceutical products.

For the full year 2024, Stevanato expects revenue in the range of €1.09 billion to €1.11 billion, in line with analysts' expectations of €1.09 billion. However, the company slightly lowered its adjusted earnings per share guidance to €0.47-€0.49, compared to the previous outlook of €0.48-€0.50.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1186717979"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1186717979\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1186717979?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-05 22:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1186717979","market":"hk","top_or_hot":-1,"title":"Stock Track | Stevanato Group Shares Surge on Q3 Earnings Beat and Revenue Outlook","media":"Stock Track","content":"<p>Shares of Stevanato Group S.p.A. (NYSE: STVN), a leading producer of glass vials for COVID-19 vaccines, soared over 5% on Monday after the company reported better-than-expected third-quarter revenue and provided an optimistic full-year revenue outlook.</p>\n\n<p>While the company's Q3 adjusted earnings of €0.12 ($0.13) per share narrowly missed analysts' estimates of €0.13, its revenue of €277.9 million surpassed the consensus estimate of €274.4 million. Stevanato attributed the revenue growth to strong demand for its pharmaceutical products.</p>\n\n<p>For the full year 2024, Stevanato expects revenue in the range of €1.09 billion to €1.11 billion, in line with analysts' expectations of €1.09 billion. However, the company slightly lowered its adjusted earnings per share guidance to €0.47-€0.49, compared to the previous outlook of €0.48-€0.50.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Stevanato Group Shares Surge on Q3 Earnings Beat and Revenue Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Stevanato Group Shares Surge on Q3 Earnings Beat and Revenue Outlook\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2024-11-05 22:50</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Shares of Stevanato Group S.p.A. (NYSE: STVN), a leading producer of glass vials for COVID-19 vaccines, soared over 5% on Monday after the company reported better-than-expected third-quarter revenue and provided an optimistic full-year revenue outlook.</p>\n\n<p>While the company's Q3 adjusted earnings of €0.12 ($0.13) per share narrowly missed analysts' estimates of €0.13, its revenue of €277.9 million surpassed the consensus estimate of €274.4 million. Stevanato attributed the revenue growth to strong demand for its pharmaceutical products.</p>\n\n<p>For the full year 2024, Stevanato expects revenue in the range of €1.09 billion to €1.11 billion, in line with analysts' expectations of €1.09 billion. However, the company slightly lowered its adjusted earnings per share guidance to €0.47-€0.49, compared to the previous outlook of €0.48-€0.50.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"STVN","symbol_name":"Stevanato Group S.p.A.","start_time":0,"source_url":"","article_id":"1186717979","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1186717979","pubTimestamp":1730818222,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Stevanato Group S.p.A. , a leading producer of glass vials for COVID-19 vaccines, soared over 5% on Monday after the company reported better-than-expected third-quarter revenue and provided an optimistic full-year revenue outlook.While the company's Q3 adjusted earnings of 0.12  per share narrowly missed analysts' estimates of 0.13, its revenue of 277.9 million surpassed the consensus estimate of 274.4 million. Stevanato attributed the revenue growth to strong demand for its pharmaceut","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"STVN":"Stevanato Group S.p.A."},"translate_title":"Stevanato Group股价因第三季度盈利超出预期和收入前景而飙升","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"STVN":1},"content_text":"Shares of Stevanato Group S.p.A. (NYSE: STVN), a leading producer of glass vials for COVID-19 vaccines, soared over 5% on Monday after the company reported better-than-expected third-quarter revenue and provided an optimistic full-year revenue outlook.\nWhile the company's Q3 adjusted earnings of €0.12 ($0.13) per share narrowly missed analysts' estimates of €0.13, its revenue of €277.9 million surpassed the consensus estimate of €274.4 million. Stevanato attributed the revenue growth to strong demand for its pharmaceutical products.\nFor the full year 2024, Stevanato expects revenue in the range of €1.09 billion to €1.11 billion, in line with analysts' expectations of €1.09 billion. However, the company slightly lowered its adjusted earnings per share guidance to €0.47-€0.49, compared to the previous outlook of €0.48-€0.50.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}